PTEN R130L [cytosol]

Stable Identifier
R-HSA-2317430
Type
Protein [EntityWithAccessionedSequence]
Species
Homo sapiens
Compartment
Synonyms
PTEN Arg130Leu
PTEN R130L [cytosol] icon
Locations in the PathwayBrowser
General
PTEN missense mutation that results in the substitution of arginine at position 130 with leucine affects the conserved H-C-K/R-A-G-K-G-R sequence (corresponding to HCXXGXXR motif of protein tyrosine phosphatases) in the catalytic cleft of the PTEN phosphatase domain. The arginine residue in this motif, corresponding to R130 of human PTEN, is essential for catalysis (Barford et al. 1994, Lee et al. 1999). PTEN R130L (Arg130Leu) mutant shows markedly decreased phosphoinositide phosphatase activity (Han et al. 2000). PTEN R130L is found as a germline mutation in Cowden syndrome, an autosomal dominant cancer syndrome (Marsh et al. 1998).
Literature References
PubMed ID Title Journal Year
9467011 Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation

Marsh, DJ, Coulon, V, Lunetta, KL, Rocca-Serra, P, Dahia, PL, Zheng, Z, Liaw, D, Caron, S, Duboué, B, Lin, AY, Richardson, AL, Bonnetblanc, JM, Bressieux, JM, Cabarrot-Moreau, A, Chompret, A, Demange, L, Eeles, RA, Yahanda, AM, Fearon, ER, Fricker, JP, Gorlin, RJ, Hodgson, SV, Huson, S, Lacombe, D, Eng, C

Hum. Mol. Genet. 1998
10866302 Functional evaluation of PTEN missense mutations using in vitro phosphoinositide phosphatase assay

Han, SY, Kato, H, Kato, S, Suzuki, T, Shibata, H, Ishii, S, Shiiba, K, Matsuno, S, Kanamaru, R, Ishioka, C

Cancer Res 2000
Participates
Other forms of this molecule
Modified Residues
Name
L-arginine 130 replaced with L-leucine
Coordinate
130
PsiMod
A protein modification that effectively converts a source amino acid residue to an L-leucine.
A protein modification that effectively removes or replaces an L-arginine.
Disease
Name Identifier Synonyms
Cowden syndrome DOID:6457 multiple hamartoma syndrome
endometrial cancer DOID:1380 primary malignant neoplasm of endometrium, neoplasm of endometrium (disorder), endometrial neoplasm, malignant endometrial neoplasm, endometrial Ca, malignant neoplasm of endometrium, tumor of Endometrium
cancer DOID:162 malignant tumor, malignant neoplasm, primary cancer
breast cancer DOID:1612 malignant tumor of the breast, mammary cancer, malignant neoplasm of breast, mammary tumor, primary breast cancer, breast cancer, Ca breast - NOS, breast tumor
Interactors (46)
Accession #Entities Entities Confidence Score Evidence (IntAct)
 UniProt:O14745 NHRF1      0.826 9
 UniProt:Q5TCQ9 MAGI3      0.747 9
 UniProt:Q15599 NHRF2      0.733 6
 UniProt:P60484 PTEN  20 0.713 19
 UniProt:O60307 MAST3      0.698 4
 UniProt:P09619 PDGFRB  3 0.675 3
 UniProt:P42685 FRK  4 0.639 7
 UniProt:Q06830 PRDX1  4 0.632 7
 UniProt:P30260 CDC27  2 0.616 7
 UniProt:Q6P0Q8 MAST2      0.611 4
 UniProt:Q9NZN5-2 ARHGEF12      0.611 4
 UniProt:Q92743 HTRA1  1 0.611 4
 UniProt:Q9H5P4 PDZD7      0.611 4
 UniProt:A4D2P6 GRD2I      0.611 4
 UniProt:Q9HD26 GOPC  3 0.611 4
 UniProt:O43791 SPOP  3 0.611 4
 UniProt:Q14160 SCRIB  1 0.611 4
 UniProt:Q9Y2H9 MAST1      0.611 4
 UniProt:Q86UL8 MAGI2  1 0.611 6
 UniProt:Q9NY99 SNTG2  1 0.611 3
 UniProt:Q96L92 SNX27      0.611 4
 UniProt:Q13424 SNTA1  1 0.611 4
 UniProt:Q13884 SNTB1  1 0.611 5
 UniProt:P35226 BMI1  3 0.61 7
 UniProt:Q9R1L5 MAST1      0.593 3
 UniProt:Q60592 MAST2      0.593 4
 UniProt:P46934 NEDD4  1 0.591 4
 UniProt:O88382 MAGI2      0.581 3
 UniProt:O75970 MPDZ      0.544 4
 UniProt:Q96QZ7 MAGI1      0.544 5
 UniProt:Q15700 DLG2  2 0.544 2
 UniProt:Q8NI35 PATJ  1 0.544 3
 UniProt:P62136 PPP1CA  2 0.524 2
 UniProt:Q9JHL1 NHRF2      0.524 2
 UniProt:P21860 ERBB3      0.519 2
 UniProt:Q9NRD5 PICK1  2 0.508 2
 UniProt:Q9JK71 MAGI3      0.508 3
 UniProt:Q9P0U4 CXXC1  1 0.508 2
 UniProt:Q03135 CAV1  5 0.499 2
 UniProt:Q9ULX6 AKAP8L  1 0.499 2
 UniProt:P08238 HSP90AB1  6 0.483 2
 UniProt:Q9UER7 DAXX  13 0.483 2
 UniProt:Q16643 DBN1  1 0.471 5
 UniProt:Q9UJX3 ANAPC7  2 0.462 2
 UniProt:Q9UJX5 ANAPC4  2 0.462 2
 UniProt:Q9UJX4 ANAPC5  2 0.462 2
Cite Us!